Researchers continue to seek strategy for starving brain tumors

June 2, 2017 by Laura Oleniacz, University of North Carolina at Chapel Hill School of Medicine

In an effort to starve brain cancer cells and put the brakes on tumor development, University of North Carolina Lineberger Comprehensive Cancer Center researchers blocked the main pathway that brain tumor cells use to convert sugar into energy. They hoped this would starve tumor cells and slow their growth. To their surprise, however, the strategy actually accelerated growth in laboratory models of medulloblastoma.

Published in the journal Cancer Research, the study was part of a series of attempts by UNC Lineberger researchers to shut down the production machinery in medulloblastoma, the most common malignant brain tumor in children. The findings may help researchers identify a suitable therapeutic target within the sugar metabolism pathway, and provide clues to a scientific mystery surrounding the confounding way that some cancer cells get energy from sugar.

"Our goal is to continue to find out what's helping cancer cells to grow, and to try to stop it," said UNC Lineberger's Timothy R. Gershon, MD, PhD, an associate professor in the UNC School of Medicine Department of Neurology. "We're going to keep taking apart this energy production pathway in cancer cells—to conduct a molecular dissection to try to find the part that makes the cancer cells go."

Gershon said previous studies have shown that cancer cells rely on a process called "aerobic glycolysis," in which oxygen is present, but cells do not use it to get the maximum amount of energy from sugar. Cells using aerobic glycolysis need to use more sugar to get the same amount of energy, Gershon said.

"This is a question that scientists first started asking in the 1920s, and we're still trying to answer it," Gershon said. "Why would cancer cells use aerobic glycolysis?"

Glycolysis produces less energy overall, and creates a byproduct known as lactic acid. Gershon and his collaborators previously showed that normal cells that replicate in the growing brain rely on aerobic glycolysis.

"While most cells only use glycolysis when oxygen is not available, cancer cells use glycolysis all of the time, even under oxygen-rich conditions," he said. "No one knows why, but many people have hoped that blocking this form of glycolysis would be a way to treat cancer."

Researchers in Gershon's lab have blocked different molecular mechanisms that cells use during glycolysis to prevent them from producing energy. Previously, they found deleting a gene involved in glycolysis, Hexokinase 2, reduced brain in preclinical models. However, Gershon said that gene would be hard to disrupt in people because it's similar to Hexokinase 1, which is vital for human survival. So, they searched for another target.

"We looked at other genes in the glycolysis pathway to see if they might be better targets for inhibitors, and to understand more about how the pathway supports cancer growth," Gershon said.

In the new study, they deleted a gene that codes for a molecule called pyruvate kinase. However, deleting this gene actually spurred cancer growth in laboratory models.

"This paper shows that some steps in glycolysis increase tumor growth, and other steps decrease tumor growth," Gershon said. "We do not know why, but it clearly makes a difference which step is targeted."

Together, the two studies show that the way cancer cells metabolize glucose significantly affects their proliferative behavior, the researchers reported. The most recent study points to actions upstream of the pyruvate kinase step as key to preventing cancer growth.

In addition to guiding future efforts to find a therapeutic target that could block cells' energy production, the researchers may have identified a possible clue as to why use this particular energy production pathway. They traced the path of sugar through the cell, and narrowed down the possibilities for where the glucose goes. Based on their findings, they speculate that medulloblastoma cells utilize the glucose to make proteins, which go into building more , rather than supplying energy.

Explore further: Oxygen-free energy designed to fuel brain development spurs on growth of cancer

Related Stories

Oxygen-free energy designed to fuel brain development spurs on growth of cancer

January 22, 2013
The metabolic process which fuels the growth of many cancers has its origins in normal brain growth finds a new study published in BioMed Central's open access journal Cancer & Metabolism. Using knock-out mice the study shows ...

Immune cells localized near pancreatic cancer cells have altered metabolism, could promote cancer

May 9, 2017
A diagnosis of pancreatic cancer is a virtual death sentence, with only 3 to 5 per cent of patients surviving beyond five years. A key reason that it has the lowest survival rate of all major cancers is that it readily spreads ...

PGK1 protein promotes brain tumor formation and cancer metabolism

March 3, 2016
PGK1, a glycolytic enzyme, has been found to play a role in coordinating cellular processes crucial to cancer metabolism and brain tumor formation, according to results published in today's online issue of Molecular Cell. ...

Targeting breast cancer metabolism to fight the disease

November 28, 2016
How does a cancer cell burn calories? New research from Thomas Jefferson University shows that breast cancer cells rely on a different process for turning fuel into energy than normal cells. The results were recently published ...

Mdm2 suppresses tumors by pulling the plug on glycolysis

February 24, 2014
Cancer cells have long been known to have higher rates of the energy-generating metabolic pathway known as glycolysis. This enhanced glycolysis, a phenomenon known as the Warburg effect, is thought to allow cancer cells to ...

Tumors disable immune cells by using up sugar

June 6, 2013
Cancer cells' appetite for sugar may have serious consequences for immune cell function, researchers at Washington University School of Medicine in St. Louis have learned.

Recommended for you

Stem cell vaccine immunizes lab mice against multiple cancers

February 15, 2018
Stanford University researchers report that injecting mice with inactivated induced pluripotent stem cells (iPSCs) launched a strong immune response against breast, lung, and skin cancers. The vaccine also prevented relapses ...

Induced pluripotent stem cells could serve as cancer vaccine, researchers say

February 15, 2018
Induced pluripotent stem cells, or iPS cells, are a keystone of regenerative medicine. Outside the body, they can be coaxed to become many different types of cells and tissues that can help repair damage due to trauma or ...

Team paves the way to the use of immunotherapy to treat aggressive colon tumors

February 15, 2018
In a short space of time, immunotherapy against cancer cells has become a powerful approach to treat cancers such as melanoma and lung cancer. However, to date, most colon tumours appeared to be unresponsive to this kind ...

Can our genes help predict how women respond to ovarian cancer treatment?

February 15, 2018
Research has identified gene variants that play a significant role in how women with ovarian cancer process chemotherapy.

First comparison of common breast cancer tests finds varied accuracy of predictions

February 15, 2018
Commercially-available prognostic breast cancer tests show significant variation in their abilities to predict disease recurrence, according to a study led by Queen Mary University of London of nearly 800 postmenopausal women.

Catching up to brain cancer: Researchers develop accurate model of how aggressive cancer cells move and spread

February 15, 2018
A brief chat at a Faculty Senate meeting put two University of Delaware researchers onto an idea that could be of great value to cancer researchers.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.